APO Research
Talk to an analyst

APO RESEARCH · REPORT

Varicella Live Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Varicella Live Vaccine Market Analysis and Forecast 2026-2032

20 December 2025196 pages

Choose your research edition.

Industry ResearchVaricella Live Vaccine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Varicella Live Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Varicella Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varicella Live Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Varicella Live Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Varicella Live Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Varicella Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Varicella Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Varicella Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Varicella Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Varicella Live Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Sanofi Pasteur, Panacea Biotec, Mitsubishi Tanabe Pharma Corporation and MedImmune, LLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Varicella Live Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Varicella Live Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Varicella Live Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Varicella Live Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Varicella Live Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Varicella Live Vaccine sales, projected growth trends, production technology, application and end-user industry.

Varicella Live Vaccine Segment by Company

Johnson & Johnson

Merck & Co., Inc.

Pfizer, Inc.

GlaxoSmithKline plc

Serum Institute of India Pvt. Ltd.

Sanofi Pasteur

Panacea Biotec

Mitsubishi Tanabe Pharma Corporation

MedImmune, LLC

Emergent BioSolutions, Inc.

Daiichi Sankyo

CSL Limited

Biological E

Bavarian Nordic

Astellas Pharma Inc.

Varicella Live Vaccine Segment by Type

Monovalent Vaccines

Multivalent Vaccines

Varicella Live Vaccine Segment by Application

Herpes Zoster Immunization

Measles Immunization

Chicken Pox Immunization

Others

Varicella Live Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varicella Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Live Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Varicella Live Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Varicella Live Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Live Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Varicella Live Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccines Major Manufacturers Table 3. Multivalent Vaccines Major Manufacturers Table 4. Global Varicella Live Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Herpes Zoster Immunization Major Manufacturers Table 6. Measles Immunization Major Manufacturers Table 7. Chicken Pox Immunization Major Manufacturers Table 8. Others Major Manufacturers Table 9. Varicella Live Vaccine Industry Trends Table 10. Varicella Live Vaccine Industry Drivers Table 11. Varicella Live Vaccine Industry Opportunities and Challenges Table 12. Varicella Live Vaccine Industry Restraints Table 13. Global Varicella Live Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Varicella Live Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Varicella Live Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Varicella Live Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Varicella Live Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Varicella Live Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Varicella Live Vaccine Sales by Region (2021-2026) & (k units) Table 20. Global Varicella Live Vaccine Sales by Region (2027-2032) & (k units) Table 21. Global Varicella Live Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Varicella Live Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Varicella Live Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Varicella Live Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Varicella Live Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Varicella Live Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Varicella Live Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Varicella Live Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Varicella Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Varicella Live Vaccine Manufacturers, Product Type & Application Table 31. Global Varicella Live Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Varicella Live Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Varicella Live Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Varicella Live Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Varicella Live Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Varicella Live Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 41. Global Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 42. Global Varicella Live Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Varicella Live Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Varicella Live Vaccine Price by Type (2021-2026) & (US$/unit) Table 45. Global Varicella Live Vaccine Price by Type (2027-2032) & (US$/unit) Table 46. Global Varicella Live Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Varicella Live Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Varicella Live Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Varicella Live Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 53. Global Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 54. Global Varicella Live Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Varicella Live Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Varicella Live Vaccine Price by Application (2021-2026) & (US$/unit) Table 57. Global Varicella Live Vaccine Price by Application (2027-2032) & (US$/unit) Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Varicella Live Vaccine Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Varicella Live Vaccine Product Portfolio Table 67. Merck & Co., Inc. Recent Development Table 68. Pfizer, Inc. Company Information Table 69. Pfizer, Inc. Business Overview Table 70. Pfizer, Inc. Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Pfizer, Inc. Varicella Live Vaccine Product Portfolio Table 72. Pfizer, Inc. Recent Development Table 73. GlaxoSmithKline plc Company Information Table 74. GlaxoSmithKline plc Business Overview Table 75. GlaxoSmithKline plc Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline plc Varicella Live Vaccine Product Portfolio Table 77. GlaxoSmithKline plc Recent Development Table 78. Serum Institute of India Pvt. Ltd. Company Information Table 79. Serum Institute of India Pvt. Ltd. Business Overview Table 80. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Product Portfolio Table 82. Serum Institute of India Pvt. Ltd. Recent Development Table 83. Sanofi Pasteur Company Information Table 84. Sanofi Pasteur Business Overview Table 85. Sanofi Pasteur Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Sanofi Pasteur Varicella Live Vaccine Product Portfolio Table 87. Sanofi Pasteur Recent Development Table 88. Panacea Biotec Company Information Table 89. Panacea Biotec Business Overview Table 90. Panacea Biotec Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Panacea Biotec Varicella Live Vaccine Product Portfolio Table 92. Panacea Biotec Recent Development Table 93. Mitsubishi Tanabe Pharma Corporation Company Information Table 94. Mitsubishi Tanabe Pharma Corporation Business Overview Table 95. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Product Portfolio Table 97. Mitsubishi Tanabe Pharma Corporation Recent Development Table 98. MedImmune, LLC Company Information Table 99. MedImmune, LLC Business Overview Table 100. MedImmune, LLC Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. MedImmune, LLC Varicella Live Vaccine Product Portfolio Table 102. MedImmune, LLC Recent Development Table 103. Emergent BioSolutions, Inc. Company Information Table 104. Emergent BioSolutions, Inc. Business Overview Table 105. Emergent BioSolutions, Inc. Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Emergent BioSolutions, Inc. Varicella Live Vaccine Product Portfolio Table 107. Emergent BioSolutions, Inc. Recent Development Table 108. Daiichi Sankyo Company Information Table 109. Daiichi Sankyo Business Overview Table 110. Daiichi Sankyo Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Daiichi Sankyo Varicella Live Vaccine Product Portfolio Table 112. Daiichi Sankyo Recent Development Table 113. CSL Limited Company Information Table 114. CSL Limited Business Overview Table 115. CSL Limited Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. CSL Limited Varicella Live Vaccine Product Portfolio Table 117. CSL Limited Recent Development Table 118. Biological E Company Information Table 119. Biological E Business Overview Table 120. Biological E Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Biological E Varicella Live Vaccine Product Portfolio Table 122. Biological E Recent Development Table 123. Bavarian Nordic Company Information Table 124. Bavarian Nordic Business Overview Table 125. Bavarian Nordic Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Bavarian Nordic Varicella Live Vaccine Product Portfolio Table 127. Bavarian Nordic Recent Development Table 128. Astellas Pharma Inc. Company Information Table 129. Astellas Pharma Inc. Business Overview Table 130. Astellas Pharma Inc. Varicella Live Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Astellas Pharma Inc. Varicella Live Vaccine Product Portfolio Table 132. Astellas Pharma Inc. Recent Development Table 133. North America Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 136. North America Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 137. North America Varicella Live Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 138. North America Varicella Live Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 139. North America Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 142. North America Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 143. North America Varicella Live Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 144. North America Varicella Live Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 145. North America Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Varicella Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Varicella Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 149. North America Varicella Live Vaccine Sales by Country (2021-2026) & (k units) Table 150. North America Varicella Live Vaccine Sales by Country (2027-2032) & (k units) Table 151. North America Varicella Live Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 152. North America Varicella Live Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 153. United States Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 154. Canada Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Mexico Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 156. Europe Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 159. Europe Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 160. Europe Varicella Live Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 161. Europe Varicella Live Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 162. Europe Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. Europe Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. Europe Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 165. Europe Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 166. Europe Varicella Live Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 167. Europe Varicella Live Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 168. Europe Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe Varicella Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Europe Varicella Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Europe Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Europe Varicella Live Vaccine Sales by Country (2021-2026) & (k units) Table 173. Europe Varicella Live Vaccine Sales by Country (2027-2032) & (k units) Table 174. Europe Varicella Live Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 175. Europe Varicella Live Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 176. Germany Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 177. France Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 178. U.K. Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Italy Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Russia Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Spain Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Netherlands Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Switzerland Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Sweden Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Poland Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 186. China Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 187. China Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 188. China Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 189. China Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 190. China Varicella Live Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 191. China Varicella Live Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 192. China Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 193. China Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 194. China Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 195. China Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 196. China Varicella Live Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 197. China Varicella Live Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 198. Asia Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 201. Asia Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 202. Asia Varicella Live Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 203. Asia Varicella Live Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 204. Asia Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 207. Asia Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 208. Asia Varicella Live Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 209. Asia Varicella Live Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 210. Asia Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Varicella Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Varicella Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. Asia Varicella Live Vaccine Sales by Country (2021-2026) & (k units) Table 215. Asia Varicella Live Vaccine Sales by Country (2027-2032) & (k units) Table 216. Asia Varicella Live Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 217. Asia Varicella Live Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 218. Japan Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 219. South Korea Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 220. India Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Australia Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Taiwan Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Varicella Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Varicella Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Varicella Live Vaccine Sales by Type (2021-2026) & (k units) Table 227. SAMEA Varicella Live Vaccine Sales by Type (2027-2032) & (k units) Table 228. SAMEA Varicella Live Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 229. SAMEA Varicella Live Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 230. SAMEA Varicella Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Varicella Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Varicella Live Vaccine Sales by Application (2021-2026) & (k units) Table 233. SAMEA Varicella Live Vaccine Sales by Application (2027-2032) & (k units) Table 234. SAMEA Varicella Live Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 235. SAMEA Varicella Live Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 236. SAMEA Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Varicella Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Varicella Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 240. SAMEA Varicella Live Vaccine Sales by Country (2021-2026) & (k units) Table 241. SAMEA Varicella Live Vaccine Sales by Country (2027-2032) & (k units) Table 242. SAMEA Varicella Live Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 243. SAMEA Varicella Live Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 244. Brazil Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 245. Argentina Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 246. Chile Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 247. Colombia Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 248. Peru Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 250. Israel Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 251. UAE Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 252. Turkey Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 253. Iran Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 254. Egypt Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Varicella Live Vaccine Distributors List Table 258. Varicella Live Vaccine Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Varicella Live Vaccine Image Figure 2. Global Varicella Live Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varicella Live Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monovalent Vaccines Image Figure 5. Multivalent Vaccines Image Figure 6. Global Varicella Live Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Varicella Live Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Herpes Zoster Immunization Image Figure 9. Measles Immunization Image Figure 10. Chicken Pox Immunization Image Figure 11. Others Image Figure 12. Global Varicella Live Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Varicella Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Varicella Live Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Varicella Live Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Varicella Live Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Varicella Live Vaccine Sales (2021-2032) & (k units) Figure 18. Global Varicella Live Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Varicella Live Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Varicella Live Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Europe Varicella Live Vaccine Sales YoY (2021-2032) & (k units) Figure 22. China Varicella Live Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Varicella Live Vaccine Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Varicella Live Vaccine Sales YoY (2021-2032) & (k units) Figure 25. Global Varicella Live Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Varicella Live Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Varicella Live Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Varicella Live Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Varicella Live Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Varicella Live Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Varicella Live Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Varicella Live Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Varicella Live Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Varicella Live Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Varicella Live Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Varicella Live Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Varicella Live Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Varicella Live Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Varicella Live Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Varicella Live Vaccine Sales Share by Type (2021-2032) Figure 42. North America Varicella Live Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Varicella Live Vaccine Sales Share by Application (2021-2032) Figure 44. North America Varicella Live Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Varicella Live Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Varicella Live Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Varicella Live Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Varicella Live Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Varicella Live Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Varicella Live Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Varicella Live Vaccine Sales Share by Country (2021-2032) Figure 52. China Varicella Live Vaccine Revenue Share by Type (2021-2032) Figure 53. China Varicella Live Vaccine Sales Share by Type (2021-2032) Figure 54. China Varicella Live Vaccine Revenue Share by Application (2021-2032) Figure 55. China Varicella Live Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Varicella Live Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Varicella Live Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Varicella Live Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Varicella Live Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Varicella Live Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Varicella Live Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Varicella Live Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Varicella Live Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Varicella Live Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Varicella Live Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Varicella Live Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Varicella Live Vaccine Sales Share by Country (2021-2032) Figure 68. Varicella Live Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Varicella Live Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Multivalent Vaccines
Applications
  • Herpes Zoster Immunization
  • Measles Immunization
  • Chicken Pox Immunization
  • Others
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Serum Institute of India Pvt. Ltd.
  • Sanofi Pasteur
  • Panacea Biotec
  • Mitsubishi Tanabe Pharma Corporation
  • MedImmune, LLC
  • Emergent BioSolutions, Inc.
  • Daiichi Sankyo
  • CSL Limited
  • Biological E
  • Bavarian Nordic
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Varicella Live Vaccine Market by Type
  3. 1.2.1 Global Varicella Live Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccines
  5. 1.2.3 Multivalent Vaccines
  6. 1.3 Varicella Live Vaccine Market by Application
  7. 1.3.1 Global Varicella Live Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Herpes Zoster Immunization
  9. 1.3.3 Measles Immunization
  10. 1.3.4 Chicken Pox Immunization
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Varicella Live Vaccine Market Dynamics
  1. 2.1 Varicella Live Vaccine Industry Trends
  2. 2.2 Varicella Live Vaccine Industry Drivers
  3. 2.3 Varicella Live Vaccine Industry Opportunities and Challenges
  4. 2.4 Varicella Live Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Varicella Live Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Varicella Live Vaccine Revenue by Region
  3. 3.2.1 Global Varicella Live Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Varicella Live Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Varicella Live Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Varicella Live Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Varicella Live Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Varicella Live Vaccine Sales by Region
  9. 3.4.1 Global Varicella Live Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Varicella Live Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Varicella Live Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Varicella Live Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Varicella Live Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Varicella Live Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Varicella Live Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Varicella Live Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Varicella Live Vaccine Sales by Manufacturers
  6. 4.2.1 Global Varicella Live Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Varicella Live Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Varicella Live Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Varicella Live Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Varicella Live Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Varicella Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Varicella Live Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Varicella Live Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Varicella Live Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Varicella Live Vaccine Tier 1, Tier 2, and Tier 3
5 Varicella Live Vaccine Market by Type
  1. 5.1 Global Varicella Live Vaccine Revenue by Type
  2. 5.1.1 Global Varicella Live Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Varicella Live Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Varicella Live Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Varicella Live Vaccine Sales by Type
  6. 5.2.1 Global Varicella Live Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Varicella Live Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Varicella Live Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Varicella Live Vaccine Price by Type
6 Varicella Live Vaccine Market by Application
  1. 6.1 Global Varicella Live Vaccine Revenue by Application
  2. 6.1.1 Global Varicella Live Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Varicella Live Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Varicella Live Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Varicella Live Vaccine Sales by Application
  6. 6.2.1 Global Varicella Live Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Varicella Live Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Varicella Live Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Varicella Live Vaccine Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Varicella Live Vaccine Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Varicella Live Vaccine Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 Pfizer, Inc.
  14. 7.3.1 Pfizer, Inc. Company Information
  15. 7.3.2 Pfizer, Inc. Business Overview
  16. 7.3.3 Pfizer, Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer, Inc. Varicella Live Vaccine Product Portfolio
  18. 7.3.5 Pfizer, Inc. Recent Developments
  19. 7.4 GlaxoSmithKline plc
  20. 7.4.1 GlaxoSmithKline plc Company Information
  21. 7.4.2 GlaxoSmithKline plc Business Overview
  22. 7.4.3 GlaxoSmithKline plc Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline plc Varicella Live Vaccine Product Portfolio
  24. 7.4.5 GlaxoSmithKline plc Recent Developments
  25. 7.5 Serum Institute of India Pvt. Ltd.
  26. 7.5.1 Serum Institute of India Pvt. Ltd. Company Information
  27. 7.5.2 Serum Institute of India Pvt. Ltd. Business Overview
  28. 7.5.3 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Product Portfolio
  30. 7.5.5 Serum Institute of India Pvt. Ltd. Recent Developments
  31. 7.6 Sanofi Pasteur
  32. 7.6.1 Sanofi Pasteur Company Information
  33. 7.6.2 Sanofi Pasteur Business Overview
  34. 7.6.3 Sanofi Pasteur Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur Varicella Live Vaccine Product Portfolio
  36. 7.6.5 Sanofi Pasteur Recent Developments
  37. 7.7 Panacea Biotec
  38. 7.7.1 Panacea Biotec Company Information
  39. 7.7.2 Panacea Biotec Business Overview
  40. 7.7.3 Panacea Biotec Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Panacea Biotec Varicella Live Vaccine Product Portfolio
  42. 7.7.5 Panacea Biotec Recent Developments
  43. 7.8 Mitsubishi Tanabe Pharma Corporation
  44. 7.8.1 Mitsubishi Tanabe Pharma Corporation Company Information
  45. 7.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
  46. 7.8.3 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Product Portfolio
  48. 7.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
  49. 7.9 MedImmune, LLC
  50. 7.9.1 MedImmune, LLC Company Information
  51. 7.9.2 MedImmune, LLC Business Overview
  52. 7.9.3 MedImmune, LLC Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MedImmune, LLC Varicella Live Vaccine Product Portfolio
  54. 7.9.5 MedImmune, LLC Recent Developments
  55. 7.10 Emergent BioSolutions, Inc.
  56. 7.10.1 Emergent BioSolutions, Inc. Company Information
  57. 7.10.2 Emergent BioSolutions, Inc. Business Overview
  58. 7.10.3 Emergent BioSolutions, Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Emergent BioSolutions, Inc. Varicella Live Vaccine Product Portfolio
  60. 7.10.5 Emergent BioSolutions, Inc. Recent Developments
  61. 7.11 Daiichi Sankyo
  62. 7.11.1 Daiichi Sankyo Company Information
  63. 7.11.2 Daiichi Sankyo Business Overview
  64. 7.11.3 Daiichi Sankyo Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Daiichi Sankyo Varicella Live Vaccine Product Portfolio
  66. 7.11.5 Daiichi Sankyo Recent Developments
  67. 7.12 CSL Limited
  68. 7.12.1 CSL Limited Company Information
  69. 7.12.2 CSL Limited Business Overview
  70. 7.12.3 CSL Limited Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 CSL Limited Varicella Live Vaccine Product Portfolio
  72. 7.12.5 CSL Limited Recent Developments
  73. 7.13 Biological E
  74. 7.13.1 Biological E Company Information
  75. 7.13.2 Biological E Business Overview
  76. 7.13.3 Biological E Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Biological E Varicella Live Vaccine Product Portfolio
  78. 7.13.5 Biological E Recent Developments
  79. 7.14 Bavarian Nordic
  80. 7.14.1 Bavarian Nordic Company Information
  81. 7.14.2 Bavarian Nordic Business Overview
  82. 7.14.3 Bavarian Nordic Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bavarian Nordic Varicella Live Vaccine Product Portfolio
  84. 7.14.5 Bavarian Nordic Recent Developments
  85. 7.15 Astellas Pharma Inc.
  86. 7.15.1 Astellas Pharma Inc. Company Information
  87. 7.15.2 Astellas Pharma Inc. Business Overview
  88. 7.15.3 Astellas Pharma Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Astellas Pharma Inc. Varicella Live Vaccine Product Portfolio
  90. 7.15.5 Astellas Pharma Inc. Recent Developments
8 North America
  1. 8.1 North America Varicella Live Vaccine Market Size by Type
  2. 8.1.1 North America Varicella Live Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Varicella Live Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Varicella Live Vaccine Price by Type (2021-2032)
  5. 8.2 North America Varicella Live Vaccine Market Size by Application
  6. 8.2.1 North America Varicella Live Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Varicella Live Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Varicella Live Vaccine Price by Application (2021-2032)
  9. 8.3 North America Varicella Live Vaccine Market Size by Country
  10. 8.3.1 North America Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Varicella Live Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Varicella Live Vaccine Market Size by Type
  2. 9.1.1 Europe Varicella Live Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Varicella Live Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Varicella Live Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Varicella Live Vaccine Market Size by Application
  6. 9.2.1 Europe Varicella Live Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Varicella Live Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Varicella Live Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Varicella Live Vaccine Market Size by Country
  10. 9.3.1 Europe Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Varicella Live Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Varicella Live Vaccine Market Size by Type
  2. 10.1.1 China Varicella Live Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Varicella Live Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Varicella Live Vaccine Price by Type (2021-2032)
  5. 10.2 China Varicella Live Vaccine Market Size by Application
  6. 10.2.1 China Varicella Live Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Varicella Live Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Varicella Live Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Varicella Live Vaccine Market Size by Type
  2. 11.1.1 Asia Varicella Live Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Varicella Live Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Varicella Live Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Varicella Live Vaccine Market Size by Application
  6. 11.2.1 Asia Varicella Live Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Varicella Live Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Varicella Live Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Varicella Live Vaccine Market Size by Country
  10. 11.3.1 Asia Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Varicella Live Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Varicella Live Vaccine Market Size by Type
  2. 12.1.1 SAMEA Varicella Live Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Varicella Live Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Varicella Live Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Varicella Live Vaccine Market Size by Application
  6. 12.2.1 SAMEA Varicella Live Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Varicella Live Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Varicella Live Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Varicella Live Vaccine Market Size by Country
  10. 12.3.1 SAMEA Varicella Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Varicella Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Varicella Live Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Varicella Live Vaccine Value Chain Analysis
  2. 13.1.1 Varicella Live Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Varicella Live Vaccine Production Mode & Process
  6. 13.2 Varicella Live Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Varicella Live Vaccine Distributors
  9. 13.2.3 Varicella Live Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst